Arterial Cannula Market’s Skyrocketing Growth: US$40 Billion by 2033 at a Steady 6.6% CAGR | FMI Report

In 2023, the global arterial cannula market achieved a significant milestone with a market value of US$ 21 billion. Projections indicate a remarkable growth trajectory, reaching a market value of US$ 40 billion within the forecast period from 2022 to 2033. This impressive ascent is largely driven by the increasing adoption of arterial cannulas in extracorporeal membrane oxygenation, commanding the largest share of the arterial cannula market in terms of applications.

Arterial cannulae play a crucial role during cardiopulmonary bypass (CPB) procedures, facilitating perfusion into the ascending aorta. These essential medical devices come in a variety of materials, including biocompatible materials, silicone, polyurethane, polyvinyl chloride (PVC), and more. Their flexibility, translucency, and feature hard or smooth plastic tips, along with secure connections, typically characterize arterial cannulas. The tip of a cannula may have a straight or curved design, often equipped with a vent plug for efficient de-airing during cannulation. Some advanced cannulas also incorporate wire reinforcement to enhance durability, reduce the risk of kinking, and optimize wall thickness.

Request a Sample Copy of the Report Now
https://www.futuremarketinsights.com/reports/sample/rep-gb-15945

The increased incidence of lifestyle disorders like obesity and diabetes is increasing the number of surgical procedures performed throughout the world. This is a significant factor that is expected to improve arterial cannula market sales. Moreover, the growing ageing population and rising demand for minimally invasive procedures (MIS) are likely to propel market growth. The worldwide arterial cannula market is predicted to increase at an exponential rate during the forecast period, owing primarily to the rising prevalence of cardiovascular illnesses. According to the American Heart Association, approximately half of all individuals in the United States had some kind of cardiovascular disease in 2019. Furthermore, according to the CDC, around 20.1 million persons aged 20 and older in the United States had coronary artery disease in 2020, accounting for approximately 7.2% of the overall population.

Furthermore, the rising popularity of aesthetic operations, as well as the expanding influence of social media, is driving up demand for arterial cannulas. In Addition to that, good government laws for delivering essential healthcare services, as well as advances in healthcare facilities are expected to drive the worldwide arterial cannula market. Furthermore, important suppliers are investing in R&D projects in order to create high-quality items.

Key Takeaways from the Market Study

• FMI projects the global arterial cannula market to expand at a 6.6% value CAGR by 2033
• The global arterial cannula market is estimated at a market value of US$ 21 Billion
• The global arterial cannula market is expected to garner a market value of US$ 40 Billion
• North America is expected to be the most lucrative for arterial cannula market growth
• As per Future Market Insights, the Asia Pacific is expected to grow at a CAGR of 6.1% in the assessment period 2023-2033.
• As per Future Market Insights, the Europe is expected to grow at a CAGR of 6.3% in the assessment period 2023-2033.
• The hospitals segment is expected to hold the largest market share for arterial cannula in the forecast period 2023-2033.

“Asian countries with large ageing populations, such as Japan, China, and India, promises significant development potential for the sector in this area,” says an analyst at FMI

Discovering the assumptions behind the study. Ask An Analyst
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15945

Market Competition:

• Medtronic, plc.
• LivaNova plc
• Edward Lifesciences
• Getinge AB
• Fresenius Medical Care
• BD, Nipro Corp.
• Andocor
• Freelife Medical GmbH
• Surgical Holdings
• Kangxin Medical.

Recent Developments:

• In April 2020, LivaNova Plc. got a CE mark for their Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula for ECMO treatments in which femoral artery cannulation can be used.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the global Arterial Cannula market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023-2033.

The study reveals essential insights on the basis of Application (ECMO, Cardiopulmonary Bypass Surgery), by Size (20-22 Fr, 35-36 Fr), by End-use (Hospitals, ASCs), across five major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts.

Grab Your Discount Now Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-15945

Key Segments Profiled in the Arterial Cannula Market Industry Survey

Arterial Cannula Market by Application:

• Extracorporeal Membrane Oxygenation (ECMO)
• Cardiopulmonary Bypass Surgery
• Others

Arterial Cannula Market by Size:

• 14-16 Fr
• 17-19 Fr
• 20-22 Fr
• 23-25 Fr
• 26-28 Fr
• 29-31 Fr
• 32-34 Fr
• 35-36 Fr

Arterial Cannula Market by End Use:

• Hospitals
• Ambulatory Surgical Centers
• Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube